| Product Code: ETC6188130 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The pharmaceutical hot melt extrusion (HME) market in Australia is expanding steadily as this technology gains traction for enhancing drug solubility and stability, particularly for poorly water-soluble drugs. The adoption of HME is also being spurred by its applications in controlled drug delivery systems and its compatibility with continuous manufacturing practices. Collaborations between Australia research institutions and pharmaceutical firms are further supporting innovation in this space.
The hot melt extrusion market in Australia is witnessing notable growth owing to its ability to enhance the solubility of poorly water-soluble drugs. Pharmaceutical companies are increasingly incorporating this technique for the development of novel drug delivery systems, particularly for oral solid dosage forms. There is also a trend toward integrating real-time process monitoring and continuous manufacturing to ensure consistent product quality.
Pharmaceutical hot melt extrusion in Australia faces slow adoption due to high costs of setup and lack of local expertise in formulation science. Material compatibility issues and the risk of thermal degradation of active ingredients also restrict broader application. Regulatory acceptance of extruded formulations is another barrier to market expansion.
Australia supports R&D-intensive technologies such as hot melt extrusion with investment policies that provide tax offsets for clinical trials and formulation development. This segment also benefits from university-industry collaboration grants and innovation hubs focused on pharmaceutical processing.
Hot melt extrusion (HME) technologies used in drug formulation are regulated as part of the manufacturing equipment framework. The TGA requires full documentation on the operational validation of such equipment to ensure consistent drug dispersal and bioavailability. Policies also support innovation in drug delivery mechanisms and the safe introduction of new polymeric excipients used in HME processes.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Pharmaceutical Hot Melt Extrusion Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Pharmaceutical Hot Melt Extrusion Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Pharmaceutical Hot Melt Extrusion Market - Industry Life Cycle |
3.4 Australia Pharmaceutical Hot Melt Extrusion Market - Porter's Five Forces |
3.5 Australia Pharmaceutical Hot Melt Extrusion Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Australia Pharmaceutical Hot Melt Extrusion Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Australia Pharmaceutical Hot Melt Extrusion Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and innovative drug delivery systems |
4.2.2 Growing emphasis on enhancing bioavailability and solubility of pharmaceutical compounds |
4.2.3 Rise in research and development activities in the pharmaceutical sector |
4.3 Market Restraints |
4.3.1 High initial investment and operational costs associated with hot melt extrusion technology |
4.3.2 Stringent regulatory requirements and quality standards in the pharmaceutical industry |
4.3.3 Limited awareness and adoption of hot melt extrusion technology among pharmaceutical manufacturers |
5 Australia Pharmaceutical Hot Melt Extrusion Market Trends |
6 Australia Pharmaceutical Hot Melt Extrusion Market, By Types |
6.1 Australia Pharmaceutical Hot Melt Extrusion Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Pharmaceutical Hot Melt Extrusion Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Australia Pharmaceutical Hot Melt Extrusion Market Revenues & Volume, By Twin Screw Extruder, 2021- 2031F |
6.1.4 Australia Pharmaceutical Hot Melt Extrusion Market Revenues & Volume, By Single Screw Extruder, 2021- 2031F |
6.1.5 Australia Pharmaceutical Hot Melt Extrusion Market Revenues & Volume, By Laboratory Extruder, 2021- 2031F |
6.1.6 Australia Pharmaceutical Hot Melt Extrusion Market Revenues & Volume, By RAM Extruder, 2021- 2031F |
6.2 Australia Pharmaceutical Hot Melt Extrusion Market, By End Users |
6.2.1 Overview and Analysis |
6.2.2 Australia Pharmaceutical Hot Melt Extrusion Market Revenues & Volume, By Research Laboratory, 2021- 2031F |
6.2.3 Australia Pharmaceutical Hot Melt Extrusion Market Revenues & Volume, By Contract Manufacturing Organization, 2021- 2031F |
6.2.4 Australia Pharmaceutical Hot Melt Extrusion Market Revenues & Volume, By Pharma Companies, 2021- 2031F |
7 Australia Pharmaceutical Hot Melt Extrusion Market Import-Export Trade Statistics |
7.1 Australia Pharmaceutical Hot Melt Extrusion Market Export to Major Countries |
7.2 Australia Pharmaceutical Hot Melt Extrusion Market Imports from Major Countries |
8 Australia Pharmaceutical Hot Melt Extrusion Market Key Performance Indicators |
8.1 Percentage increase in the number of patents filed for pharmaceutical formulations using hot melt extrusion |
8.2 Number of new product launches utilizing hot melt extrusion technology |
8.3 Percentage growth in research collaborations and partnerships focused on hot melt extrusion in the pharmaceutical sector |
9 Australia Pharmaceutical Hot Melt Extrusion Market - Opportunity Assessment |
9.1 Australia Pharmaceutical Hot Melt Extrusion Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Australia Pharmaceutical Hot Melt Extrusion Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Australia Pharmaceutical Hot Melt Extrusion Market - Competitive Landscape |
10.1 Australia Pharmaceutical Hot Melt Extrusion Market Revenue Share, By Companies, 2024 |
10.2 Australia Pharmaceutical Hot Melt Extrusion Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |